Assertio Holdings Inc (ASRT)

03:49 AM

Geode Capital Management LLC Purchases 42,750 Shares of Assertio Holdings, Inc. (NASDAQ:ASRT) - Defense World

03:49 AM

Jan 03, 2025

Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Jan 03, 2025

Jan 03, 2025

Assertio Holdings Names New Chief Commercial Officer, Awards Major Stock Incentive Package - StockTitan

Jan 03, 2025

Jan 02, 2025

Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Assertio Holdings, Inc. - AccessWire

Jan 02, 2025

Dec 31, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Up 14.1% in December - MarketBeat

Dec 31, 2024

Dec 24, 2024

Is Assertio Holdings (NASDAQ:ASRT) A Risky Investment? - Simply Wall St

Dec 24, 2024

Dec 18, 2024

Assertio appoints new independent director to board By Investing.com - Investing.com South Africa

Dec 18, 2024

Dec 17, 2024

Assertio appoints new independent director to board - Investing.com

Dec 17, 2024

Dec 17, 2024

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors - The Manila Times

Dec 17, 2024

Dec 17, 2024

Assertio Holdings Taps Former Astellas President Who Led $5B Sales Growth to Join Board - StockTitan

Dec 17, 2024

Dec 17, 2024

Assertio’s (ASRT) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Dec 17, 2024

Dec 16, 2024

Assertio Therapeutics shares get buy rating on clinical trial results By Investing.com - Investing.com Canada

Dec 16, 2024

Dec 16, 2024

Assertio (NASDAQ:ASRT) Receives Buy Rating from HC Wainwright - MarketBeat

Dec 16, 2024

Dec 15, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Short Interest Down 11.5% in November - MarketBeat

Dec 15, 2024

Dec 14, 2024

Assertio reports positive Rolvedon trial results for breast cancer By Investing.com - Investing.com Australia

Dec 14, 2024

Dec 13, 2024

Assertio Announces Results of Rolvedon (Eflapegrastim-Xnst) Injection Same-Day Dosing Clinical Study - Marketscreener.com

Dec 13, 2024

Dec 13, 2024

Assertio reports positive Rolvedon trial results for breast cancer - Investing.com

Dec 13, 2024

Dec 13, 2024

Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study - The Manila Times

Dec 13, 2024

Dec 12, 2024

Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO - The Manila Times

Dec 12, 2024

Dec 12, 2024

Assertio Holdings Creates Transformation Office, Appoints New Leadership to Drive Growth Strategy - StockTitan

Dec 12, 2024

Dec 06, 2024

Assertio Holdings Inc (NASDAQ: ASRT): Blank Check On Growth? - Stocks Register

Dec 06, 2024

Dec 06, 2024

Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer - GlobeNewswire Inc.

Dec 06, 2024

Dec 06, 2024

Beam Therapeutics names Sravan K. Emany as new CFO - Investing.com

Dec 06, 2024

Nov 28, 2024

HC Wainwright Forecasts Stronger Earnings for Assertio - MarketBeat

Nov 28, 2024

Nov 25, 2024

Assertio shares hold price target, buy rating on stable Indocin share By Investing.com - Investing.com Canada

Nov 25, 2024

Nov 25, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Shares Acquired by Empowered Funds LLC - Defense World

Nov 25, 2024

Nov 20, 2024

Assertio Holdings Q3 2024 Earnings Preview - MSN

Nov 20, 2024

Nov 20, 2024

Assertio stock gains amid Q3 earnings, clash with activist investor - MSN

Nov 20, 2024

Nov 19, 2024

Insider Buying: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Acquires $60,000.00 in Stock - MarketBeat

Nov 19, 2024

Nov 19, 2024

Assertio Holdings director Heather Mason buys $60,000 in shares By Investing.com - Investing.com Nigeria

Nov 19, 2024

Nov 19, 2024

Assertio Holdings director Heather Mason buys $60,000 in shares - Investing.com

Nov 19, 2024

Nov 15, 2024

Assertio Holdings CEO Brendan O'Grady buys $9,950 in common stock - Investing.com India

Nov 15, 2024

Nov 15, 2024

Spectrum Pharma Faces Senate Probe Call Over Alleged Rolvedon Data Fraud | ASRT Stock News - StockTitan

Nov 15, 2024

Nov 14, 2024

Assertio Holdings Inc (ASRT) Quarterly 10-Q Report - Quartz

Nov 14, 2024

Nov 13, 2024

Assertio Holdings Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 13, 2024

Nov 12, 2024

Assertio Holdings, Inc. (NASDAQ:ASRT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 12, 2024

Nov 12, 2024

Assertio Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 12, 2024

Nov 12, 2024

Assertio: Q3 Earnings Snapshot - The Washington Post

Nov 12, 2024

Nov 11, 2024

Assertio Therapeutics’ Q3 2024 Earnings Overview - TipRanks

Nov 11, 2024

Nov 11, 2024

Assertio stock gains amid Q3 earnings, clash with activist investor (NASDAQ:ASRT) - Seeking Alpha

Nov 11, 2024

Nov 11, 2024

Assertio (ASRT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 11, 2024

Nov 11, 2024

Assertio Holdings, Inc. Announces Board Changes - Marketscreener.com

Nov 11, 2024

Nov 11, 2024

Assertio Holdings Faces SEC Whistleblower Complaint Over Alleged Clinical Data Fraud | ASRT Stock News - StockTitan

Nov 11, 2024

Nov 11, 2024

Assertio Provides Response to Letter from Short-seller - GlobeNewswire

Nov 11, 2024

Nov 11, 2024

Assertio Holdings CEO Fires Back at Short-Seller's 'Baseless' Rolvedon Claims | ASRT Stock News - StockTitan

Nov 11, 2024

Nov 09, 2024

Assertio Holdings (NASDAQ:ASRT investor five-year losses grow to 72% as the stock sheds US$17m this past week - Simply Wall St

Nov 09, 2024

Nov 08, 2024

Assertio faces fraud claims, investor goes short on stock By Investing.com - Investing.com India

Nov 08, 2024

Nov 08, 2024

Assertio Stock Alert: Major Investor Warns of Fraud Claims, Safety Issues in Spectrum Deal | ASRT Stock News - StockTitan

Nov 08, 2024